Core Viewpoint - Chengdi Xiangjiang has received an administrative regulatory measure from the Shanghai Securities Regulatory Bureau due to inaccurate financial report data disclosures for multiple reporting periods, leading to a warning letter issued to the company and its former chairman [1][3]. Financial Reporting Errors - The company has identified three main categories of accounting errors affecting seven financial reports, including the consolidated balance sheet and income statement [1][2]. - The first category involves internal transaction offsetting issues, where the company misreported internal sales losses, leading to understated operating costs and overstated inventory and revenue [1][2]. - The second category pertains to misclassification of right-of-use asset amortization, where expenses were incorrectly categorized, distorting data in several financial statement categories [2]. - The third category includes delayed revenue recognition for five specific projects, which resulted in inaccuracies in reported operating income and retained earnings for the affected periods [2][3]. Correction and Regulatory Response - On June 30, 2025, the company disclosed a correction announcement, adjusting accounts receivable by 40.41 million, operating income by 62.19 million, operating costs by 105 million, and reducing retained earnings by 35.31 million in the corrected 2023 annual report [3]. - The Shanghai Securities Regulatory Bureau has issued warning letters to the company and responsible individuals, emphasizing the violations of regulations due to the accounting errors [3][4]. - The company has committed to enhancing regulatory compliance and internal controls to prevent future occurrences, asserting that the regulatory measures will not significantly impact its operations [4].